Sun.Jun 11, 2023

article thumbnail

STAT+: Francis deSouza’s tenure at Illumina is a lesson in how not to handle CEO succession

STAT

The sudden resignation of Francis deSouza as the CEO of Illumina Sunday represents anything but an orderly transition — and it leaves a black mark on both his six-year tenure and his luckless quest to acquire the cancer diagnostics firm Grail. But when the story of deSouza’s time as CEO is taught in management classes, it may be that the discussion should not just be about the decisions he made at the end.

275
275
article thumbnail

Deal value decreased by 16 per cent in May 2023, compared to May 2022

Express Pharma

In May 2023, the healthcare industry reported 80 deals worth $16.3 billion compared to the last 12-month average (May 2022 to April 2023) of 79 deals worth $17 billion. A consortium led by Elliott Investment Management enters into an agreement to acquire Syneos Health Inc, an integrated biopharma solutions organisation for a consideration of approximately $7.1 billion; Advent International Corp and Warburg Pincus LLC to acquire Baxter Biopharma Solutions, a provider of sterile contract manufactu

Diabetes 117
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Following board fight, Francis deSouza resigns as Illumina CEO

STAT

Just two weeks after surviving an activist investor’s attempt to oust him from Illumina’s board, company CEO Francis deSouza has resigned his roles at the sequencing behemoth, Illumina said Sunday. deSouza stepped down effectively immediately from the CEO position and from the company’s board. He will remain an adviser through next month.

259
259
article thumbnail

FDA approves new cell therapy manufacturing plant

European Pharmaceutical Review

The US Food and Drug Administration (FDA) has approved commercial production at Bristol Myers Squibb’s newest cell therapy manufacturing facility in Devens, Massachusetts. The 244,000 square foot facility in Devens is BMS’ third commercial cell therapy facility in the US. It is located on the company’s existing Devens site, which has been developing, producing, and testing clinical and commercial medicines for over a decade.

93
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: Kura Oncology highlights leukemia remission data as it enrolls larger trial

STAT

FRANKFURT — A genetically targeted cancer drug from Kura Oncology has helped put more patients’ advanced leukemias into remission, according to updated results from an ongoing clinical trial presented Sunday. Based on data through April 12, 7 of the 20 patients who received a daily dose of 600 milligrams of the company’s drug saw their cancer go into complete remission, a rate of 35%, according to findings presented here at the European Hematology Association’s annual

212
212
article thumbnail

Novartis builds hefty IgAN pipeline with $3.5bn Chinook buy

pharmaphorum

Novartis builds hefty IgAN pipeline with $3.5bn Chinook buy Phil.

97

More Trending

article thumbnail

Episode 825: Are We Using the Wrong Definition of Oliguria?

Pharmacy Joe

In this episode, I’ll discuss an alternative definition of oliguria. Episode 825: Are We Using the Wrong Definition of Oliguria? Subscribe on iTunes , Android , or Stitcher The commonly used definition of oliguria is a urine output of 0.5 mL/kg/hr over a 6 hr period. However some small studies have suggested that this definition of oliguria is too liberal.

article thumbnail

Masterclass on The What, When and How of Brand Review

PharmaState Academy

???????????: To be awarded with 3CPhE (Continuing Pharma Education) points. Registrations Open now Limited Seats! BOOK SEAT for $5 Invest in yourself! Masterclass: The What, When, and How of Brand Review - Learn the right way of doing a Brand Review 2nd July 2023 (Sunday) 10:00 AM - 12:00 PM (IST) Days Hours Minutes Seconds Masterclass: The What, When, and How of Brand Review - Learn the right way of doing a Brand Review 2nd July 2023 (Sunday) 10:00 AM - 12:00 PM (IST) Days Hours Minutes Seconds

article thumbnail

Acute Paronychia

RX Note

Introduction Paronychia is an inflammation involving the lateral and proximal nail folds. It may be Acute - characterized by the rapid onset of painful erythema and swelling of proximal and lateral nail folds, usually in 2-5 days following a minor local trauma. A superficial abscess is present; lasting for <6 weeks. Chronic - gradual process and commonly occurs in individuals persistently exposed to environmental irritants and allergens (e.g. wet work, food, chemicals).

article thumbnail

PTCB Free Practice Test

Med Ed 101

I’ve had numerous pharmacy technicians and future pharmacy technicians reach out to me over the years for more content to help them prepare for board exams. I’m happy to support more pharmacy peeps than just pharmacists. The biggest challenge for pharmacy technicians has been the PTCB® (Pharmacy Technician Certification Board) exam. We’ve gone through the content […] The post PTCB Free Practice Test appeared first on Med Ed 101.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Benign Skin Lesions

RX Note

Introduction A skin lesion is a part of the skin that has an abnormal growth or appearance compared to the skin around it. Common benign skin lesions have typical clinical characteristics and appearances. Certain lesions, such as nevi, milia, dermatofibroma, skin tags, pyogenic granuloma, keratosis pilaris, syringoma are more common in children and younger adults.

article thumbnail

CMS extends list of drugs with penalties for price hikes

pharmaphorum

CMS extends list of drugs with penalties for price hikes Phil.

89
article thumbnail

Medscape

RX Note

Introduction Medscape is a comprehensive medical resource that provide up-to-date information on drugs, diseases and clinical procedures, which only requires a FREE account registration. It was launched to the world on 22 May 1995. Other features include medical news and CME & Education. Mobile Application Mobile application for Medscape was released in 2009 and 2011 for iOS and Android system respectively.

52
article thumbnail

Glutathione (GSH): Your Natural Shield for Health and Vitality

Welltopia Pharmacy

The tripeptide antioxidant glutathione is a vital component of our body's defence mechanism. It promotes general health and shields our cells from harm.

52
article thumbnail

Illumina CEO resigns amid investor pressure

pharmaphorum

Illumina CEO resigns amid investor pressure Phil.

83
article thumbnail

Roche Presents P-III Studies (COMMODORE 1 & 2) Results of Crovalimab for the Treatment of Paroxysmal Nocturnal Haemoglobinuria at EHA 2023

PharmaShots

Shots: The P-III studies evaluating crovalimab (SC, q4w) vs eculizumab (IV, q2w) in a ratio (1:1) & (2:1) in 89 & 204 patients. In the (COMMODORE 2) study, 79.3% vs 79.0% achieved haemolysis control from 5wk. to 25wk., transfusion avoidance (65.7% vs 68.1%) from baseline to 25wk. Improvement in FACIT-fatigue score from baseline to 25wk. across both arms with greater improvement with crovalimab (adjusted mean change 7.8 vs 5.2), AEs (78% vs 80%), serious inf. (3% vs 7%) with no meningococ

40
article thumbnail

PREA is All You Need? FDA’s Recent Draft Guidance States an Intention to Limit Pediatric Exclusivity By Issuing Fewer Written Requests Under the BPCA

FDA Law Blog: Biosimilars

By Mark A. Tobolowsky & David B. Clissold — In May 2023, CDER and CBER published a draft guidance titled “Pediatric Drug Development: Regulatory Considerations – Complying with the Pediatric Research Equity Act [“PREA”] and Qualifying for Pediatric Exclusivity Under the Best Pharmaceuticals for Children Act [“BPCA”]” (the “Draft Guidance”). This Draft Guidance, in part, replaces a 2005 guidance titled “How to Comply with the Pediatric Research Equity Act.

article thumbnail

Online Medical Resources

RX Note

Introduction This post is soley created as a portal for online medical resources. Some of the resources require personal subscription to access. Antibiotics Johns Hopkins ABX Guide Sanford Guide Stanford Health Care Antimicrobial Guidebook Breastfeeding e-lactania InfantRisk Center LactMed MotherToBaby Pregnancy and Breastfeeding Medicines Guide Calculator ClinCalc GlobalRPh MDCalc Clinical Practice BMJ Best Practice DynaMed ESPEN eTG complete Essential Evidence Plus Global Initiative for Asthma

article thumbnail

Focusing on the Patient Journey in Specialty Pharmacy is Essential

Pharmacy Times

Denise Scarpelli, PharmD, MBA, discussed her presentation at the ASHP 2023 Summer Meeting.

article thumbnail

Corns and Calluses

RX Note

Introduction Corns and calluses are common skin lesions in which there is a localized area of hard, thickened skin. Different from warts , corns and calluses are caused by response to friction and pressure. Repetitive injury results in the skin trying to protect itself from blistering. The most common site for a corn or a callus is on the hand or foot, but any area of skin may be affected.